EIN: 203068945 · Tax Year 2018 · Source: IRS Form 990
| Metric | Amount |
|---|---|
| Total Revenue | $356K |
| Total Expenses | $382K |
| Net Income | $-26,472 |
| Total Assets (End of Year) | $618K |
Congenital Hyperinsulinism International reported $356K in total revenue for the 2018 tax year, with $382K in total expenses and $618K in net assets.
Detailed spending breakdown data is not available for Congenital Hyperinsulinism International's 2018 filing.
This data comes from Congenital Hyperinsulinism International's IRS Form 990 filed for the 2018 tax year. Form 990 is a public document that all tax-exempt organizations must file annually with the IRS.
The IRS Form 990 is a public document that tax-exempt organizations must file annually. It provides detailed information about an organization's finances, governance, and activities. Key sections include revenue and expenses, compensation of officers, and program accomplishments.
All data shown on this page comes directly from Congenital Hyperinsulinism International's publicly available IRS Form 990 for the 2018 tax year. This information is provided for transparency and research purposes.